NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Fadoi Foundation, Italy
Academic and Community Cancer Research United
Daiichi Sankyo
Assistance Publique - Hôpitaux de Paris
University of Rochester
University Medical Center Groningen
Ontario Clinical Oncology Group (OCOG)